The relationship between C-reactive protein/albumin ratio and mortality in hypertensive patients: a national cohort study

Rongting Zhang,Yani Wang,Lihua Liao,Ying Liao,Yong Fang,Yunli Shen
DOI: https://doi.org/10.1016/j.numecd.2024.02.011
IF: 4.666
2024-02-29
Nutrition Metabolism and Cardiovascular Diseases
Abstract:Background and Aims The impact of inflammation on the prognosis of hypertension has received some attention. The current study examined the association between C-reactive protein to albumin ratio (CAR), a novel indicator of inflammatory response, and mortality in individuals with hypertension. Methods and results A total of 9,561 eligible individuals diagnosed with hypertension were included in the final analysis. CAR was calculated as ratio of C-reactive protein to serum albumin concentration. Patients were categorized into tertiles based on their baseline CAR levels. The Kaplan-Meier survival method was employed to compare the survival times of patients throughout the follow-up period. Multivariable analysis was conducted using the Cox proportional regression model. In the entire study population, 3,262 (27%) experienced all-cause mortality. Patients in tertile 3 exhibited a higher risk of mortality (23% vs. 28% vs. 31%, P < 0.001) in comparison to those in the other tertiles. The findings from the multivariable Cox regression analysis demonstrated that when patients in tertile 1 were used as the reference group, the highest CAR tertile displayed a 60% increased risk of all-cause mortality (HR, 1.60 [95%CI, 1.23–2.09] P < 0.001). Conclusion Among hypertensive patients, elevated CAR was found to be associated with an increased risk of all-cause mortality. Therefore, CAR might be used for risk stratification within this population, facilitating the implementation of closer follow-up and the optimization of treatment strategies.
cardiac & cardiovascular systems,endocrinology & metabolism,nutrition & dietetics
What problem does this paper attempt to address?